Dae Hwa Pharm Co Liabilities 2024

Liabilities Details

Assessing Dae Hwa Pharm Co's Liabilities

Dae Hwa Pharm Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Dae Hwa Pharm Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Dae Hwa Pharm Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Dae Hwa Pharm Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Dae Hwa Pharm Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Dae Hwa Pharm Co stock

What is the level of liabilities of Dae Hwa Pharm Co this year?

Dae Hwa Pharm Co has a debt balance of 145.93 B KRW this year.

What were the liabilities of Dae Hwa Pharm Co compared to the previous year?

The liabilities of Dae Hwa Pharm Co have increased by 20.54% increased compared to the previous year.

What are the consequences of high debt for investors of Dae Hwa Pharm Co?

High liabilities can pose a risk for investors of Dae Hwa Pharm Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Dae Hwa Pharm Co?

Low liabilities mean that Dae Hwa Pharm Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Dae Hwa Pharm Co affect the company?

An increase in liabilities of Dae Hwa Pharm Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Dae Hwa Pharm Co affect the company?

A decrease in the liabilities of Dae Hwa Pharm Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Dae Hwa Pharm Co?

Some factors that can influence the liabilities of Dae Hwa Pharm Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Dae Hwa Pharm Co so important for investors?

The liabilities of Dae Hwa Pharm Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Dae Hwa Pharm Co take to modify the liabilities?

To change its liabilities, Dae Hwa Pharm Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Dae Hwa Pharm Co pay?

Over the past 12 months, Dae Hwa Pharm Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 1.28 %. For the coming 12 months, Dae Hwa Pharm Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Dae Hwa Pharm Co?

The current dividend yield of Dae Hwa Pharm Co is 1.28 %.

When does Dae Hwa Pharm Co pay dividends?

Dae Hwa Pharm Co pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Dae Hwa Pharm Co?

Dae Hwa Pharm Co paid dividends every year for the past 20 years.

What is the dividend of Dae Hwa Pharm Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 1.28 %.

In which sector is Dae Hwa Pharm Co located?

Dae Hwa Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dae Hwa Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dae Hwa Pharm Co from 8/23/2024 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Dae Hwa Pharm Co pay the last dividend?

The last dividend was paid out on 8/23/2024.

What was the dividend of Dae Hwa Pharm Co in the year 2023?

In the year 2023, Dae Hwa Pharm Co distributed 150 KRW as dividends.

In which currency does Dae Hwa Pharm Co pay out the dividend?

The dividends of Dae Hwa Pharm Co are distributed in KRW.